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 Validation of Pharmacophore model: A good correlation was 
found to exist between best fit values and pIC50 values 













 Molecular  Docking  
 Reported inhibitors were docked in the developed homology 
model of MurC ligas enzyme, within a distance of 10 Å of  
the active site as predicted by LigPlot of  PDBsum software. 
 Most of the inhibitors were found to undergo interactions with 
3 key residues i.e. Gly125, Lys126 and Arg332 
 There was a satisfactory correlation between IC50 and Glide 













Figure 4: Best GScore inhibitor showing interaction with important  
                 MurC cavity residues. 










 MurC ligase is a potential target for the treatment of TB infection. 
 Pharmacophore mapping of MurC ligase inhibitors yielded essential 
features for a lead to act against the enzyme. 
 Molecular Docking studies  with the designed ligands revealed im-
portant ligand interacting residues i.e. Gly125, Lys126, Glu170 and 
Arg332. 
 These results can aid in further drug development against             
Mycobacterium tuberculosis infections. 
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 Materials and Methods 
(a) Structure of Molecules 
  50 molecules  belonging to 4 different chemical classes were chosen from  
    Literature. 
 Structures were drawn using Sybyl7.1 installed on Silicon Graphics Fuel        
workstation. 
 All molecules were minimized with Powell’s conjugate gradient method  
   using MMFF94 force field. 
 
(b) Pharmacophore mapping  
 3D-QSAR ligand based pharmacophore model was generated using transition state 
inhibitors and pulvinone series reported in literature. 
 HipHop Pharmacophore model was developed using Catalyst module of Accelrys 
Discovery Studio 2.5. 
 50 molecules were divided into 3 classes:  Active, Moderately active and least active. 
 Training set constituted of 10 molecules and remaining molecules were assigned to 
test set. 
 The model was then validated using test set and the model was used for virtual 
screening of Zinc database and Maybridge database. 
 The hits obtained from above were subjected to molecular docking studies. 
 
(c) Molecular Docking  
 Molecular docking was performed using Glide 4.5 module of Maestro 8.5.207. 
 Poses which are closest to the bound ligand in template protein crystal structure 




















Figure 2– Molecule series chosen for Pharmacophore mapping (from left to right) 1) N-Acyl Hy-
drazones 2) Pulvinic acid 3) N-Benzyl Rhodanine and 4) Phosphinate series. 
 
Results and Discussion 
 The Pharmacophore mapping of MurC ligase inhibitors yielded a map with          
following features:  one ring aromatic, two acceptors, one hydrophobe with a fit 














Figure 3 –Pharmacophore map of MurC ligase inhibitors 
 
 The ligands were aligned with the Pharmacophore map and correlation between the 
IC50 values and fit values were established. 
 Table 1 displays ligands with the best fit values and their corresponding pIC50  
      values. 
Introduction  
Tuberculosis: The Problem 
 1.7 billion people affected worldwide 
 8 million new cases annually 
 3 million deaths per year 
 Treatment is difficult and requires long courses of    
multiple antibiotics 
 Multidrug resistant TB (MDR-TB) populations       
emergence within the TB species, remains unaffected by 
traditional TB treatments 
 Prevention relies on screening programs and               
vaccination, usually with Bacillus Calmette-Guerin     
vaccine 
 Targeting cell wall biosynthesis  is a prime area for      














 Member  of Mur amide Ligase super family (MurA-X). 
 Catalyses ligation of L-alanine (Ala) and UDP N- acetyl-
muramic acid (UNAM) to form UDP-N-acetylmuramoyl-
L-alanine (UMA). 
 Essential  enzyme for survival in 7 species of                 







 First line drugs ( INH, Rifampicin ) 
 Second line drugs (Streptomycin ,PAS) 
 Combination therapy (DOTS) 
 Development of Resistance 
 Nephrotoxicity and Hepatotoxicity 
 Ototoxicity 
 Ocular toxicity 
Targeting MurC ligase 
S. 
No. 
Name of compound pIC50  
Fit  
value 
1 Pulvinamide 8.6513 4 
2 Pulvinic acid 8.48 3.985 
3 Vulpinic acid 7.5826 3.976 
4 Pulvinone_11a 7.2130 2.815 
5 Disubstituted Pulvinone_18b 6.1934 2.723 
6 Disubstituted Pulvinone_20d 5.9120 2.658 
7 Nbenzylidene sulfonohydrazide_11h 4.9870 2.423 
8 Disubstituted Pulvinone_20b 3.9306 2.207 
Molecule GScore H-bonding residues 
NBenz_5c -7.4623 Gly125, Lys126, Glu170, 
Arg332 
NAcylhyd_19 -5.8512 Gly125, Lys126, Glu170 
NBenz_5c -5.0450 Gly124, Lys126, Glu170 
NBenz_11c -4.7091 Gly125, Gly126, Arg331 
Pulvinone_20b -4.4805 Gly125, Lys126, Glu170 
Pulvinamide -4.1000 Gly125, Lys126, Arg332 
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